Benzodiazepine sedatives linked to higher rates of mortality compared to propofol

From the Medical Xpress September 30, 2014

http://medicalxpress.com/news/2014-09-benzodiazepine-sedatives-linked-higher-mortality.html

Sedation is frequently required for mechanically ventilated intensive care unit (ICU) patients to reduce anxiety, provide comfort, and assist in providing optimal respiratory support. It is estimated that each year, there are nearly 1 million U.S. patients treated with a continuous, intravenous sedative in an ICU setting.

 

A University of Utah study shows for the first time that continuous infusion benzodiazepines – a class of sedatives that includes lorazepam and midazolam, once considered the standard of care in the ICU – are linked to an increased likelihood of death among patients who receive mechanical ventilation, when compared to the sedative propofol. The research was published in the American Journal of Respiratory Critical Care Medicine (AJRCCM).

"We found there are better, safer ways than benzodiazepines to sedate people that can still deliver all the sedation you need while minimizing some of the complications associated with mechanical ventilation," says senior author Richard Barton, M.D., professor of surgery and director of the surgical intensive care unit (SICU) at University of Utah Hospital.

The authors analyzed data on 13,692 mechanically ventilated patients from 104 U.S. hospitals during the years 2003 – 2009. They found that overall ICU mortality was 19.7 percent in propofol treated patients as compared to 28.8 percent in midazolam treated patients, and 19.3 percent for propofol compared to 25.2 percent for lorazepam treated patients. Those treated with benzodiazepines also spent significantly more time on mechanical ventilation, and a longer time in the ICU.

"Patients with renal failure and liver dysfunction have trouble clearing benzodiazepines and are more likely to be over-sedated," explains the principal author Nick Lonardo, Pharm.D. pharmacy clinical care coordinator for the SICU. "By staying on a ventilator longer, this puts patients at higher risk for developing ventilator-associated pneumonia and many of the other complications, including delirium, that come from being sedated for long periods in an ICU."

Although this is the first study to associate benzodiazepines with increased mortality, a number of smaller studies suggest that this class of drugs is associated with other adverse outcomes, especially delirium. Separate studies have linked delirium seen in the ICU to an increased risk for death. These smaller reports have already triggered a drop in the use of benzodiazepines over the last 10 years. This study found that within the data from the 104 intensive care units analyzed, there were nearly three times as many patients treated with propofol as compared to benzodiazepines.

Source: http://medicalxpress.com/news/2014-09-benz...